Afficher la notice abrégée

dc.contributor.editorTalero, Elena
dc.contributor.editorÁvila-Román, Javier
dc.date.accessioned2022-01-11T13:50:36Z
dc.date.available2022-01-11T13:50:36Z
dc.date.issued2021
dc.identifierONIX_20220111_9783036525167_884
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/77052
dc.description.abstractThis Special Issue covers both the in vitro and in vivo evaluation of marine carotenoids with anti-inflammatory and anticancer activities as well as clinical trials conducted in humans. Among the properties of carotenoids discussed in this book, it is worth highlighting the potential of astaxanthin and its precursor metabolite, adonixanthin, since oral administration of these carotenoids has shown beneficial effects on glioblastoma for the first time by suppressing cell proliferation and migration. In addition, astaxanthin has been shown to inhibit Helicobacter pylori-induced gastric carcinoma cell motility and, consequently, cancer progression through the inhibition of cytoskeleton reorganization. In addition, a carotenoid-containing lipid extract of Gloeothece sp. has demonstrated antioxidant, anti-inflammatory, and anticancer properties in vitro.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.otherHelicobacter pylori
dc.subject.othergastric carcinoma
dc.subject.otherastaxanthin
dc.subject.othercell motility
dc.subject.othercell migration
dc.subject.otherbioavailability
dc.subject.othercarotenoids
dc.subject.othermarine
dc.subject.othernanoformulation
dc.subject.otheroxidative stress
dc.subject.otherreactive oxygen species
dc.subject.otherbrain
dc.subject.othercancer
dc.subject.otheroral administration
dc.subject.otherparacoccsu carotinifaciens
dc.subject.otherxanthophyll carotenoid
dc.subject.otherphotodamage
dc.subject.otherskin cancer
dc.subject.otherphotoaging
dc.subject.othermarine carotenoids
dc.subject.otherfucoxanthin
dc.subject.otherxanthophylls
dc.subject.othernatural compounds
dc.subject.otheralgae
dc.subject.otherbioactive
dc.subject.otherhealth
dc.subject.otherneuroprotective agent
dc.subject.otherneuroinflammation
dc.subject.otherneurological diseases
dc.subject.othermicroalgae
dc.subject.otherinflammation
dc.subject.otherbreast cancer
dc.subject.otherbacterioruberin
dc.subject.otherantioxidant
dc.subject.otherpro-oxidant
dc.subject.otherlutein
dc.subject.otherβ-carotene
dc.subject.otherlinolenic acid
dc.subject.otherlinoleic acid
dc.subject.otherlipidic compounds
dc.subject.otherPUFAs
dc.titleMarine Carotenoids in Inflammation and Cancer
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-2517-4
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036525167
oapen.relation.isbn9783036525174
oapen.pages234
oapen.place.publicationBasel, Switzerland


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/